Clinical Trials Logo

Clinical Trial Summary

The patients who infected with Carbapenem resistant Klebsiella pneumoniae were high mortality rate. Appropriate antibiotics therapy adjusted by Pharmacokinetic/Pharmacodynamic plays an important role in determining outcomes in Critically ill patients. Consequently, standard antibiotics dose may not be adequate to achieve pharmacokinetic/pharmacodynamic target in Critically ill patients. The purpose of this study is to compare the clinical outcomes between the critically ill patients who received antibiotics dose adjusted by pharmacokinetic/pharmacodynamic using Monte Carlo simulation and historical critically ill patients who received antibiotics from standard practice.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05862402
Study type Interventional
Source Phramongkutklao College of Medicine and Hospital
Contact Sujareenoot Suya, PharmD
Phone 66814738170
Email Auensujareenoot@gmail.com
Status Recruiting
Phase Phase 4
Start date May 7, 2023
Completion date June 30, 2024